Plasmapheresis in the treatment of glomerulonephritis: indications and complications

American Journal of Kidney Diseases

Volumn 36, Issue 2, 2000, Pages

  Sanz Guajardo, Dâmaso ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; PLASMAPHERESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; KIDNEY DISEASE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; SHORT SURVEY; TREATMENT INDICATION; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

GLOMERULONEPHRITIS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

IMMUNOSUPPRESSIVE AGENT; STEROID;

EID: 0034238461     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.9016     Document Type: Article

References (9)

1. Lockwood CM, Boulton-Jones JM, Lowental RM, Simpson U, Peters DK, Wilson DB: Recovery from Goodpasture's syndrome after inmunosuppressive treatment and plasmapheresis. Br Med J 2:252, 1975
2. Sanz-Guajardo D, Barbolla ML, Femdndez-Fernandez J, Gallego JL, Anaya A, Botella J: Tratamiento eon Plasmaféresis de las Glomerulonefritis extracapilares. Med Clin 74:337-341,1980
3. Botella J, Barbolla L, Sanz-Guajardo D, Ferndndez J, Gallego JL, Torres MT, Ferndndez M, Vegazo I: Plasmapheresis treatment in diffuse extracapillary glomerulonephritis without immune complexes or linear deposits, in Siebarth HG (ed): Plasma Exchange Plasmapheresis-Plasma Separation. New York, NY, FK Schattauer Verlag, 1980, pp 195-199
4. Leitman SF, Kucera E, McLeod B: Guidelines for Therapeutic Hemapheresis. Bethesda, MD, American Association of Blood Banks, 1992
5. a Ediciôn. Madrid, Spain, Ediciones Norma, 1997, pp 1207-1232
6. Onundarson PT, Rowe JM, Heal JM, Francis CUT: Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura: A 10-year experience at a single institution. Arch Intern Med 152:791-796, 1992
7. Jindal KK: Management of idiopathic cescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations. Kidney Int 55:S33-S40, 1999 (suppl 70)
8. a Ediciôn. Madrid, Spain, Ediciones Norma, 1993, pp 769-796
9. Mitwalli AH: Adding plasmapheresis to corticoste' roids and alkylating agents: Does it benefit patients with focal segmental glomerulosclerosis? Nephrol Dial Transplant 13:1524-1528,1998